{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T22:27:34Z","timestamp":1790893654552,"version":"4.1.0"},"reference-count":97,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.bioorg.2026.109536","type":"journal-article","created":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T15:55:11Z","timestamp":1769010911000},"page":"109536","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Pharmacological inhibition of histone Lactylation enhances immunotherapy efficacy in gastrointestinal cancers"],"prefix":"10.1016","volume":"170","author":[{"given":"Boao","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueyan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2026.109536_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2024.104586","article-title":"Comprehensive review of signaling pathways and therapeutic targets in gastrointestinal cancers","volume":"206","author":"Ji","year":"2025","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.bioorg.2026.109536_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116802","article-title":"Targeting non-histone methylation in gastrointestinal cancers: from biology to clinic","volume":"278","author":"Sun","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109536_bb0015","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/978-3-031-61238-1_14","article-title":"Immunotherapy in gastrointestinal cancers","volume":"192","author":"Lote","year":"2024","journal-title":"Cancer Treat. Res."},{"key":"10.1016\/j.bioorg.2026.109536_bb0020","doi-asserted-by":"crossref","DOI":"10.3390\/cells12071049","article-title":"Current strategy to treat immunogenic gastrointestinal cancers: perspectives for a new era","volume":"12","author":"Shimozaki","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.bioorg.2026.109536_bb0025","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2025.2486519","article-title":"Gut microbiota in hepatocellular carcinoma immunotherapy: immune microenvironment remodeling and gut microbiota modification","volume":"17","author":"Huang","year":"2025","journal-title":"Gut Microbes"},{"key":"10.1016\/j.bioorg.2026.109536_bb0030","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s40164-024-00591-7","article-title":"Biomechanics in the tumor microenvironment: from biological functions to potential clinical applications","volume":"14","author":"Peng","year":"2025","journal-title":"Exp. Hematol. Oncol."},{"key":"10.1016\/j.bioorg.2026.109536_bb0035","article-title":"Tumor microenvironment: nurturing cancer cells for immunoevasion and druggable vulnerabilities for cancer immunotherapy","volume":"611","author":"Yu","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bioorg.2026.109536_bb0040","article-title":"Epigenetic regulation of stromal and immune cells and therapeutic targets in the tumor microenvironment","volume":"15","author":"Liu","year":"2025","journal-title":"Biomolecules"},{"key":"10.1016\/j.bioorg.2026.109536_bb0045","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1007\/s13258-024-01554-2","article-title":"The impact of histone lactylation on the tumor microenvironment and metabolic pathways and its potential in cancer therapy","volume":"46","author":"Zhou","year":"2024","journal-title":"Genes Genomics"},{"key":"10.1016\/j.bioorg.2026.109536_bb0050","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.2147\/JHC.S458734","article-title":"Research Progress on the role of epigenetic methylation modification in hepatocellular carcinoma","volume":"11","author":"Wang","year":"2024","journal-title":"J Hepatocell Carcinoma"},{"key":"10.1016\/j.bioorg.2026.109536_bb0055","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/cac2.12546","article-title":"Converting \"cold\" to \"hot\": epigenetics strategies to improve immune therapy effect by regulating tumor-associated immune suppressive cells","volume":"44","author":"Tang","year":"2024","journal-title":"Cancer Commun. (Lond.)"},{"key":"10.1016\/j.bioorg.2026.109536_bb0060","article-title":"Lactate and lysine lactylation of histone regulate transcription in cancer","volume":"10","author":"Yang","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.bioorg.2026.109536_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116982","article-title":"Advances in the interaction of glycolytic reprogramming with lactylation","volume":"177","author":"Li","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bioorg.2026.109536_bb0070","article-title":"Lactate-mediated lactylation in human health and diseases: Progress and remaining challenges","author":"Hu","year":"2024","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.bioorg.2026.109536_bb0075","article-title":"Lactylation: an innovative approach to disease control","author":"Jiang","year":"2024","journal-title":"Aging Dis."},{"key":"10.1016\/j.bioorg.2026.109536_bb0080","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1186\/s12935-024-03429-8","article-title":"The relationship and clinical significance of lactylation modification in digestive system tumors","volume":"24","author":"Wang","year":"2024","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.bioorg.2026.109536_bb0085","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1007\/s12272-025-01570-0","article-title":"Histone lactylation in gastrointestinal cancers: developing immunotherapeutic drugs targeting epigenetics","volume":"48","author":"Huang","year":"2025","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.bioorg.2026.109536_bb0090","doi-asserted-by":"crossref","DOI":"10.1186\/s12957-025-04099-0","article-title":"Emerging role of histone and non-histone lactylation in metabolic reprogramming of female-specific malignancies","author":"Sun","year":"2025","journal-title":"World J. Surg. Oncol."},{"key":"10.1016\/j.bioorg.2026.109536_bb0095","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s13148-024-01682-2","article-title":"Lactylation: the novel histone modification influence on gene expression, protein function, and disease","volume":"16","author":"Hu","year":"2024","journal-title":"Clin. Epigenetics"},{"key":"10.1016\/j.bioorg.2026.109536_bb0100","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1384948","article-title":"A review of lactate-lactylation in malignancy: its potential in immunotherapy","volume":"15","author":"Zha","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bioorg.2026.109536_bb0105","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1495221","article-title":"The role of histone post-translational modifications in cancer and cancer immunity: functions, mechanisms and therapeutic implications","volume":"15","author":"Duan","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bioorg.2026.109536_bb0110","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.tig.2022.03.010","article-title":"DNA methylation: a historical perspective","volume":"38","author":"Mattei","year":"2022","journal-title":"Trends Genet."},{"key":"10.1016\/j.bioorg.2026.109536_bb0115","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/s41580-021-00441-y","article-title":"Modulation of cellular processes by histone and non-histone protein acetylation","volume":"23","author":"Shvedunova","year":"2022","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bioorg.2026.109536_bb0120","doi-asserted-by":"crossref","first-page":"5691","DOI":"10.1039\/D1CS00991E","article-title":"Dissecting the role of protein phosphorylation: a chemical biology toolbox","volume":"51","author":"Bilbrough","year":"2022","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.bioorg.2026.109536_bb0125","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/s41418-020-00708-5","article-title":"Ubiquitination in the regulation of inflammatory cell death and cancer","volume":"28","author":"Cockram","year":"2021","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.bioorg.2026.109536_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.mam.2021.100964","article-title":"The role of O-glycosylation in human disease","volume":"79","author":"Magalhaes","year":"2021","journal-title":"Mol. Aspects Med."},{"key":"10.1016\/j.bioorg.2026.109536_bb0135","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nrm.2016.140","article-title":"Metabolic regulation of gene expression through histone acylations","volume":"18","author":"Sabari","year":"2017","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bioorg.2026.109536_bb0140","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/s41586-019-1678-1","article-title":"Metabolic regulation of gene expression by histone lactylation","volume":"574","author":"Zhang","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.bioorg.2026.109536_bb0145","article-title":"Lactylation, an emerging hallmark of metabolic reprogramming: current progress and open challenges","volume":"10","author":"Liu","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"issue":"206\u2013213","key":"10.1016\/j.bioorg.2026.109536_bb0150","article-title":"Non-enzymatic lysine Lactoylation of glycolytic enzymes","volume":"27","author":"Gaffney","year":"2020","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.bioorg.2026.109536_bb0155","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.70070","article-title":"Lactylation in cancer: mechanisms in tumour biology and therapeutic potentials","volume":"14","author":"He","year":"2024","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.bioorg.2026.109536_bb0160","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s41418-021-00841-9","article-title":"Lactate promotes macrophage HMGB1 lactylation, acetylation, and exosomal release in polymicrobial sepsis","volume":"29","author":"Yang","year":"2022","journal-title":"Cell Death Differ."},{"issue":"1660\u20131677","key":"10.1016\/j.bioorg.2026.109536_bb0165","article-title":"Lactylation-driven METTL3-mediated RNA m(6)a modification promotes immunosuppression of tumor-infiltrating myeloid cells","volume":"82","author":"Xiong","year":"2022","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bioorg.2026.109536_bb0170","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1002\/cbic.202000883","article-title":"Sirtuin 2 regulates protein LactoylLys modifications","volume":"22","author":"Jennings","year":"2021","journal-title":"Chembiochem"},{"key":"10.1016\/j.bioorg.2026.109536_bb0175","doi-asserted-by":"crossref","first-page":"eabi6696","DOI":"10.1126\/sciadv.abi6696","article-title":"Class I histone deacetylases (HDAC1-3) are histone lysine delactylases","volume":"8","author":"Moreno-Yruela","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.bioorg.2026.109536_bb0180","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1021\/acschembio.1c00863","article-title":"Uncovering robust Delactoylase and Depyruvoylase activities of HDAC isoforms","volume":"17","author":"Zessin","year":"2022","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.bioorg.2026.109536_bb0185","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.1038\/s41467-024-47900-6","article-title":"HBO1 catalyzes lysine lactylation and mediates histone H3K9la to regulate gene transcription","volume":"15","author":"Niu","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioorg.2026.109536_bb0190","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2314128121","article-title":"KAT8-catalyzed lactylation promotes eEF1A2-mediated protein synthesis and colorectal carcinogenesis","volume":"121","author":"Xie","year":"2024","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bioorg.2026.109536_bb0195","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1186\/s13046-022-02477-0","article-title":"PCSK9 promotes the progression and metastasis of colon cancer cells through regulation of EMT and PI3K\/AKT signaling in tumor cells and phenotypic polarization of macrophages","volume":"41","author":"Wang","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.bioorg.2026.109536_bb0200","article-title":"Histone lactylation inhibits RARgamma expression in macrophages to promote colorectal tumorigenesis through activation of TRAF6-IL-6-STAT3 signaling","volume":"43","author":"Li","year":"2024","journal-title":"Cell Rep."},{"key":"10.1016\/j.bioorg.2026.109536_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2025.107726","article-title":"Gut microbiota reshapes the TNBC immune microenvironment: emerging immunotherapeutic strategies","volume":"215","author":"Huang","year":"2025","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bioorg.2026.109536_bb0210","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1038\/s41388-024-03080-7","article-title":"Tumor-resident microbiota contributes to colorectal cancer liver metastasis by lactylation and immune modulation","volume":"43","author":"Gu","year":"2024","journal-title":"Oncogene"},{"key":"10.1016\/j.bioorg.2026.109536_bb0215","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/s41467-024-44779-1","article-title":"Mutant KRAS-activated circATXN7 fosters tumor immunoescape by sensitizing tumor-specific T cells to activation-induced cell death","volume":"15","author":"Zhou","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioorg.2026.109536_bb0220","doi-asserted-by":"crossref","first-page":"8979","DOI":"10.1038\/s41598-017-08150-3","article-title":"A prospective analysis of mucosal microbiome-metabonome interactions in colorectal cancer using a combined MAS 1HNMR and metataxonomic strategy","volume":"7","author":"Kinross","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2026.109536_bb0225","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1186\/s12967-024-05991-1","article-title":"METTL1 mediates PKM m7G modification to regulate CD155 expression and promote immune evasion in colorectal cancer","volume":"22","author":"Wang","year":"2024","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.bioorg.2026.109536_bb0230","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/s41392-023-01605-2","article-title":"STAT5 promotes PD-L1 expression by facilitating histone lactylation to drive immunosuppression in acute myeloid leukemia","volume":"8","author":"Huang","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bioorg.2026.109536_bb0235","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/labinvest.2009.11","article-title":"Inhibition of STAT5 induces G1 cell cycle arrest and reduces tumor cell invasion in human colorectal cancer cells","volume":"89","author":"Xiong","year":"2009","journal-title":"Lab. Invest."},{"key":"10.1016\/j.bioorg.2026.109536_bb0240","doi-asserted-by":"crossref","first-page":"3589","DOI":"10.1158\/0008-5472.CAN-23-3513","article-title":"H3K18 Lactylation potentiates immune escape of non-small cell lung Cancer","volume":"84","author":"Zhang","year":"2024","journal-title":"Cancer Res."},{"key":"10.1016\/j.bioorg.2026.109536_bb0245","article-title":"Identification of lactylation related model to predict prognostic, tumor infiltrating immunocytes and response of immunotherapy in gastric cancer","volume":"14","author":"Yang","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bioorg.2026.109536_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116120","article-title":"H3K18 lactylation-mediated VCAM1 expression promotes gastric cancer progression and metastasis via AKT-mTOR-CXCL1 axis","volume":"222","author":"Zhao","year":"2024","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bioorg.2026.109536_bb0255","doi-asserted-by":"crossref","first-page":"C487","DOI":"10.1152\/ajpcell.00124.2024","article-title":"Hypoxia conduces the glioma progression by inducing M2 macrophage polarization via elevating TNFSF9 level in a histone-lactylation-dependent manner","volume":"327","author":"Li","year":"2024","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.bioorg.2026.109536_bb0260","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1485580","article-title":"Lactylation-related gene signature accurately predicts prognosis and immunotherapy response in gastric cancer","volume":"14","author":"Sun","year":"2024","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bioorg.2026.109536_bb0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2024.111462","article-title":"CAF-secreted LOX promotes PD-L1 expression via histone Lactylation and regulates tumor EMT through TGFbeta\/IGF1 signaling in gastric Cancer","volume":"124","author":"Li","year":"2024","journal-title":"Cell. Signal."},{"key":"10.1016\/j.bioorg.2026.109536_bb0270","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2024.1340124","article-title":"Cancer-associated fibroblasts: protagonists of the tumor microenvironment in gastric cancer","volume":"11","author":"Ozmen","year":"2024","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.bioorg.2026.109536_bb0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2024.102188","article-title":"Identification of cancer-associated fibrolast subtypes and distinctive role of MFAP5 in CT-detected extramural venous invasion in gastric cancer","volume":"51","author":"Gao","year":"2025","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.bioorg.2026.109536_bb0280","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s12943-024-02008-9","article-title":"Positive feedback regulation between glycolysis and histone lactylation drives oncogenesis in pancreatic ductal adenocarcinoma","volume":"23","author":"Li","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bioorg.2026.109536_bb0285","article-title":"CTCF enhances pancreatic cancer progression via FLG-AS1-dependent epigenetic regulation and macrophage polarization","author":"Liu","year":"2024","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.bioorg.2026.109536_bb0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217117","article-title":"Histone lactylation dynamics: unlocking the triad of metabolism, epigenetics, and immune regulation in metastatic cascade of pancreatic cancer","volume":"598","author":"Wang","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bioorg.2026.109536_bb0295","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-000957","article-title":"TIGIT in cancer immunotherapy","volume":"8","author":"Chauvin","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.bioorg.2026.109536_bb0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.107933","article-title":"TIM-3: an update on immunotherapy","volume":"99","author":"Zhao","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.bioorg.2026.109536_bb0305","doi-asserted-by":"crossref","first-page":"18642","DOI":"10.1038\/s41598-023-46057-4","article-title":"Integrated analysis of histone lysine lactylation (Kla)-specific genes suggests that NR6A1, OSBP2 and UNC119B are novel therapeutic targets for hepatocellular carcinoma","volume":"13","author":"Wu","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2026.109536_bb0310","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1002\/cac2.12607","article-title":"Targeting SRSF10 might inhibit M2 macrophage polarization and potentiate anti-PD-1 therapy in hepatocellular carcinoma","volume":"44","author":"Cai","year":"2024","journal-title":"Cancer Commun. (Lond.)"},{"key":"10.1016\/j.bioorg.2026.109536_bb0315","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/1751-2980.13218","article-title":"IRF5 promotes glycolysis in the progression of hepatocellular carcinoma and is regulated by TRIM35","volume":"24","author":"Fang","year":"2023","journal-title":"J. Dig. Dis."},{"key":"10.1016\/j.bioorg.2026.109536_bb0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2024.111522","article-title":"FGF21 affects the glycolysis process via mTOR-HIF1alpha axis in hepatocellular carcinoma","volume":"126","author":"Khan","year":"2025","journal-title":"Cell. Signal."},{"key":"10.1016\/j.bioorg.2026.109536_bb0325","doi-asserted-by":"crossref","DOI":"10.4161\/onci.28862","article-title":"Role of cancer stem cell-associated inflammation in creating pro-inflammatory tumorigenic microenvironments","volume":"3","author":"Jinushi","year":"2014","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.bioorg.2026.109536_bb0330","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.107634","article-title":"FGF21 alleviates chronic inflammatory injury in the aging process through modulating polarization of macrophages","volume":"96","author":"Kang","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.bioorg.2026.109536_bb0335","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.semcancer.2022.10.009","article-title":"Targeting lactate-related cell cycle activities for cancer therapy","volume":"86","author":"Lin","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.bioorg.2026.109536_bb0340","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.semnephrol.2019.04.007","article-title":"The Warburg effect, lactate, and nearly a century of trying to cure Cancer","volume":"39","author":"Spencer","year":"2019","journal-title":"Semin. Nephrol."},{"issue":"848\u2013865","key":"10.1016\/j.bioorg.2026.109536_bb0345","article-title":"Increased lactate secretion by Cancer cells sustains non-cell-autonomous adaptive resistance to MET and EGFR targeted therapies","volume":"28","author":"Apicella","year":"2018","journal-title":"Cell Metab."},{"key":"10.1016\/j.bioorg.2026.109536_bb0350","doi-asserted-by":"crossref","first-page":"E330","DOI":"10.1152\/ajpendo.00159.2022","article-title":"Lactylation: novel epigenetic regulatory and therapeutic opportunities","volume":"324","author":"Fan","year":"2023","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.bioorg.2026.109536_bb0355","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1111\/bjh.12819","article-title":"A multicentre phase II study of vorinostat in patients with relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma","volume":"165","author":"Ogura","year":"2014","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bioorg.2026.109536_bb0360","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1200\/JCO.2014.59.2782","article-title":"Belinostat in patients with relapsed or refractory peripheral T-cell lymphoma: results of the pivotal phase II BELIEF (CLN-19) study","volume":"33","author":"O'Connor","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bioorg.2026.109536_bb0365","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41408-018-0154-8","article-title":"Combining carfilzomib and panobinostat to treat relapsed\/refractory multiple myeloma: results of a multiple myeloma research consortium phase I study","volume":"9","author":"Kaufman","year":"2019","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.bioorg.2026.109536_bb0370","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108487","article-title":"HCAR1\/MCT1 regulates tumor ferroptosis through the lactate-mediated AMPK-SCD1 activity and its therapeutic implications","volume":"33","author":"Zhao","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.bioorg.2026.109536_bb0375","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/imr.12846","article-title":"The immunological Warburg effect: can a metabolic-tumor-stroma score (MeTS) guide cancer immunotherapy?","volume":"295","author":"Siska","year":"2020","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.bioorg.2026.109536_bb0380","doi-asserted-by":"crossref","DOI":"10.3390\/cells9020510","article-title":"Lactate in sarcoma microenvironment: much more than just a waste product","volume":"9","author":"Taddei","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.bioorg.2026.109536_bb0385","doi-asserted-by":"crossref","first-page":"5829","DOI":"10.1038\/onc.2017.188","article-title":"Tumor cell-derived lactate induces TAZ-dependent upregulation of PD-L1 through GPR81 in human lung cancer cells","volume":"36","author":"Feng","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.bioorg.2026.109536_bb0390","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/2084195","article-title":"Targeting L-lactate metabolism to overcome resistance to immune therapy of melanoma and other tumor entities","volume":"2019","author":"Feichtinger","year":"2019","journal-title":"J. Oncol."},{"key":"10.1016\/j.bioorg.2026.109536_bb0395","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s13059-021-02308-z","article-title":"Histone lactylation drives oncogenesis by facilitating m(6)a reader protein YTHDF2 expression in ocular melanoma","volume":"22","author":"Yu","year":"2021","journal-title":"Genome Biol."},{"key":"10.1016\/j.bioorg.2026.109536_bb0400","doi-asserted-by":"crossref","first-page":"3242","DOI":"10.2174\/0929867324666170209103444","article-title":"Lactate dehydrogenase inhibition: biochemical relevance and therapeutical potential","volume":"26","author":"Lagana","year":"2019","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109536_bb0405","doi-asserted-by":"crossref","DOI":"10.1038\/oncsis.2014.16","article-title":"Identification of LDH-A as a therapeutic target for cancer cell killing via (i) p53\/NAD(H)-dependent and (ii) p53-independent pathways","volume":"3","author":"Allison","year":"2014","journal-title":"Oncogenesis"},{"key":"10.1016\/j.bioorg.2026.109536_bb0410","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1073\/pnas.0914433107","article-title":"Inhibition of lactate dehydrogenase a induces oxidative stress and inhibits tumor progression","volume":"107","author":"Le","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bioorg.2026.109536_bb0415","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11091372","article-title":"Targeting pyruvate kinase M2 and lactate dehydrogenase a is an effective combination strategy for the treatment of pancreatic Cancer","volume":"11","author":"Mohammad","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bioorg.2026.109536_bb0420","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/cmdc.201100471","article-title":"Galloflavin (CAS 568-80-9): a novel inhibitor of lactate dehydrogenase","volume":"7","author":"Manerba","year":"2012","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bioorg.2026.109536_bb0425","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110986","article-title":"Tumor metabolite lactate promotes tumorigenesis by modulating MOESIN lactylation and enhancing TGF-beta signaling in regulatory T cells","volume":"39","author":"Gu","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.bioorg.2026.109536_bb0430","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/s41586-019-0977-x","article-title":"Breast cancer cells rely on environmental pyruvate to shape the metastatic niche","volume":"568","author":"Elia","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.bioorg.2026.109536_bb0435","doi-asserted-by":"crossref","DOI":"10.1038\/s44319-025-00661-9","article-title":"Structure-guided screening identifies tucatinib as dual inhibitor for MCT1\/2","author":"Xu","year":"2025","journal-title":"EMBO Rep."},{"key":"10.1016\/j.bioorg.2026.109536_bb0440","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1158\/1078-0432.CCR-22-2263","article-title":"A phase I dose-escalation study of AZD3965, an Oral monocarboxylate transporter 1 inhibitor, in patients with advanced Cancer","volume":"29","author":"Halford","year":"2023","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bioorg.2026.109536_bb0445","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s13402-023-00775-z","article-title":"Beyond metabolic waste: lysine lactylation and its potential roles in cancer progression and cell fate determination","volume":"46","author":"Wang","year":"2023","journal-title":"Cell. Oncol. (Dordr.)"},{"key":"10.1016\/j.bioorg.2026.109536_bb0450","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/s41421-022-00398-y","article-title":"SIRT2 functions as a histone delactylase and inhibits the proliferation and migration of neuroblastoma cells","volume":"8","author":"Zu","year":"2022","journal-title":"Cell Discov."},{"key":"10.1016\/j.bioorg.2026.109536_bb0455","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.117959","article-title":"Medicinal chemistry approaches to the discovery and development of p300\/CBP inhibitors for cancer therapy","volume":"297","author":"Wang","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109536_bb0460","doi-asserted-by":"crossref","first-page":"6523","DOI":"10.1038\/s41467-023-42025-8","article-title":"Lactylation of METTL16 promotes cuproptosis via m(6)A-modification on FDX1 mRNA in gastric cancer","volume":"14","author":"Sun","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioorg.2026.109536_bb0465","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1038\/s41375-020-01010-6","article-title":"A phase 1b\/2 study of duvelisib in combination with FCR (DFCR) for frontline therapy for younger CLL patients","volume":"35","author":"Davids","year":"2021","journal-title":"Leukemia"},{"key":"10.1016\/j.bioorg.2026.109536_bb0470","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1186\/s12974-024-03303-4","article-title":"Lactate metabolism and histone lactylation in the central nervous system disorders: impacts and molecular mechanisms","volume":"21","author":"Wang","year":"2024","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.bioorg.2026.109536_bb0475","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116331","article-title":"Comprehensive review of histone lactylation: structure, function, and therapeutic targets","volume":"225","author":"Xu","year":"2024","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bioorg.2026.109536_bb0480","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108985","article-title":"Targeted protein degradation in pancreatic cancer: advances and challenges of PROTAC-based therapeutics","volume":"165","author":"Huang","year":"2025","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.109536_bb0485","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216896","article-title":"Lactate and lactylation: behind the development of tumors","volume":"591","author":"Dai","year":"2024","journal-title":"Cancer Lett."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826000726?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826000726?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T21:10:07Z","timestamp":1770066607000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206826000726"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":97,"alternative-id":["S0045206826000726"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.109536","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacological inhibition of histone Lactylation enhances immunotherapy efficacy in gastrointestinal cancers","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.109536","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109536"}}